Analyst Ratings for West Pharmaceutical (WST)
WST Rating Summary
WST Price Target Summary
- Highest: $390.00 (Evercore ISI)
- Lowest: $265.00 (Barclays)
- Average: $324.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$324.56 (+32%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Avg. $ Target:
$324.56 (+32%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/11/2025 | Nephron | N/A | Upgrade | Buy (Hold) |
N/A (N/A) |
266.96 (245.86) |
-7.9% | Details |
| 12/2/2025 | Morgan Stanley | Kallum Titchmarsh | New Coverage | Equalweight (N/A) |
285.00 (N/A) |
277.25 (245.86) |
-11.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
